Expression of the CXCR6 on polymorphonuclear neutrophils in pancreatic carcinoma and in acute, localized bacterial infections

Clinical and Experimental Immunology

Volumn 154, Issue 2, 2008, Pages 216-223

  Gaida, M M ^a   Gunther F ^a   Wagner, C ^a   Friess, H ^b   Giese, N A ^a   Schmidt, J ^a   Hansch G M ^a   Wente, M N ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Acute bacterial infections; CXCR6; Pancreatic carcinoma; Polymorphonuclear neutrophils

Indexed keywords

CHEMOKINE RECEPTOR CXCR6; CXCL16 CHEMOKINE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BACTERIAL INFECTION; BLOOD SAMPLING; CELL ACTIVATION; CELL INFILTRATION; CELL MIGRATION; CHEMOTAXIS; CLINICAL EXAMINATION; CONFOCAL LASER MICROSCOPY; CYTOFLUOROMETRY; DEBRIDEMENT; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LEUKOCYTE; NEUTROPHIL; PANCREAS CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; SOFT TISSUE INFECTION; TUMOR BIOPSY;

ACUTE DISEASE; BACTERIAL INFECTIONS; CHEMOTAXIS, LEUKOCYTE; HUMANS; LIGANDS; MICROSCOPY, CONFOCAL; NEOPLASM PROTEINS; NEUTROPHIL ACTIVATION; NEUTROPHILS; OSTEOMYELITIS; PANCREATIC NEOPLASMS; PROSTHESIS-RELATED INFECTIONS; RECEPTORS, CHEMOKINE; RECEPTORS, VIRUS; SOFT TISSUE INFECTIONS; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 53349089998     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2008.03745.x     Document Type: Article

References (44)

1. Boisvert J, Kunkel EJ, Campbell JJ, Keeffe EB, Butcher EC, Greenberg HB. Liver-infiltrating lymphocytes in end-stage hepatitis C virus: subsets, activation status, and chemokine receptor phenotypes. J Hepatol 2003 38 : 67 75.
2. Heydtmann M, Lalor PF, Eksteen JA, Hubscher SG, Briskin M, Adams DH. CXC chemokine ligand 16 promotes integrin-mediated adhesion of liver- infiltrating lymphocytes to cholangiocytes and hepatocytes within the inflamed human liver. J Immunol 2005 174 : 1055 62.
3. Sato T, Thorlacius H, Johnston B et al. Role for CXCR6 in recruitment of activated CD8+ lymphocytes to inflamed liver. J Immunol 2005 174 : 277 83.
4. Wang J, Holmes TH, Cheung R, Greenberg HB, He XS. Expression of chemokine receptors on intrahepatic and peripheral lymphocytes in chronic hepatitis C infection: its relationship to liver inflammation. J Infect Dis 2004 190 : 989 97.
5. Morgan AJ, Guillen C, Symon FA et al. Expression of CXCR6 and its ligand CXCL16 in the lung in health and disease. Clin Exp Allergy 2005 35 : 1572 80.
6. Nanki T, Shimaoka T, Hayashida K, Taniguchi K, Yonehara S, Miyasaka N. Pathogenic role of the CXCL16-CXCR6 pathway in rheumatoid arthritis. Arthritis Rheum 2005 52 : 3004 14.
7. Aglas F, Hermann J, Egger G. Abnormal directed migration of blood polymorphonuclear leukocytes in rheumatoid arthritis. Potential role in increased susceptibility to bacterial infections. Med Inflamm 1998 7 : 19 23.
8. Iking-Konert C, Ostendorf B, Sander O et al. Transdifferentiation of polymorphonuclear neutrophils to dendritic-like cells at the site of inflammation in rheumatoid arthritis: evidence for activation by T cells. Ann Rheum Dis 2005 64 : 1436 42.
9. Silberer H, Kuppers B, Mickisch O et al. Fecal leukocyte proteins in inflammatory bowel disease and irritable bowel syndrome. Clin Lab 2005 51 : 117 26.
10. di Carlo E, Iezzi M, Pannellini T et al. Neutrophils in anti-cancer immunological strategies: old players in new games. J Hematother Stem Cell Res 2001 10 : 739 48.
11. Chin AC, Parkos CA. Neutrophil transepithelial migration and epithelial barrier function in IBD: potential targets for inhibiting neutrophil trafficking. Ann N Y Acad Sci 2006 1072 : 276 87.
12. Heydtmann M, Adams DH. Understanding selective trafficking of lymphocyte subsets. Gut 2002 50 : 150 2.
13. Wagner JG, Driscoll KE, Roth RA. Inhibition of pulmonary neutrophil trafficking during endotoxemia is dependent on the stimulus for migration. Am J Respir Cell Mol Biol 1999 20 : 769 76.
14. Sordi V, Malosio ML, Marchesi F et al. Bone marrow mesenchymal stem cells express a restricted set of functionally active chemokine receptors capable of promoting migration to pancreatic islets. Blood 2005 106 : 419 27.
15. Tamamori Y, Sawada T, Nishihara T et al. Granulocyte-colony stimulating factor enhances chimeric antibody Nd2 dependent cytotoxicity against pancreatic cancer mediated by polymorphonuclear neutrophils. Int J Oncol 2002 21 : 649 54.
16. Wagner C, Kaksa A, Muller W et al. Polymorphonuclear neutrophils in posttraumatic osteomyelitis: cells recovered from the inflamed site lack chemotactic activity but generate superoxides. Shock 2004 22 : 108 15.
17. Wente MN, Mayer C, Gaida MM et al. CXCL14 expression and potential function in pancreatic cancer. Cancer Lett 2008 259 : 209 17.
18. Wagner C, Kondella K, Bernschneider T, Heppert V, Wentzensen A, Hansch GM. Post-traumatic osteomyelitis: analysis of inflammatory cells recruited into the site of infection. Shock 2003 20 : 503 10.
19. Wagner C, Hansch GM. Genetic deficiency of CD16, the low-affinity receptor for immunoglobulin G, has no impact on the functional capacity of polymorphonuclear neutrophils. Eur J Clin Invest 2004 34 : 149 55.
20. Brenneis H, Schmidt A, Blaas-Mautner P, Worner I, Ludwig R, Hansch GM. Chemotaxis of polymorphonuclear neutrophils (PMN) in patients suffering from recurrent infection. Eur J Clin Invest 1993 23 : 693 8.
21. Abel S, Hundhausen C, Mentlein R et al. The transmembrane CXC-chemokine ligand 16 is induced by IFN-gamma and TNF-alpha and shed by the activity of the disintegrin-like metalloproteinase ADAM10. J Immunol 2004 172 : 6362 72.
22. Gough PJ, Garton KJ, Wille PT, Rychlewski M, Dempsey PJ, Raines EW. A disintegrin and metalloproteinase 10-mediated cleavage and shedding regulates the cell surface expression of CXC chemokine ligand 16. J Immunol 2004 172 : 3678 85.
23. Kayed H, Jiang X, Keleg S et al. Regulation and functional role of the Runt- related transcription factor-2 in pancreatic cancer. Br J Cancer 2007 97 : 1106 15.
24. Gaida MM, Haag N, Mayer C et al. CXCL16, CXCR6 and a distintegrin and matrix metalloproteinase (ADAM10) - an interplay leading to progression of pancreatic cancer? HPB (Oxford) 2008 10 : 215 (Abstract).
25. Kobayashi SD, Voyich JM, Burlak C, DeLeo FR. Neutrophils in the innate immune response. Arch Immunol Ther Exp (Warsz) 2005 53 : 505 17.
26. Wagner C, Iking-Konert C, Hug F et al. Cellular inflammatory response to persistent localized Staphylococcus aureus infection: phenotypical and functional characterization of polymorphonuclear neutrophils (PMN). Clin Exp Immunol 2006 143 : 70 7.
27. Ruegg C. Leukocytes, inflammation, and angiogenesis in cancer: fatal attractions. J Leukoc Biol 2006 80 : 682 4.
28. de Visser KE, Eichten A, Coussens LM. Paradoxical roles of the immune system during cancer development. Nat Rev Cancer 2006 6 : 24 37.
29. Nelson D, Ganss R. Tumor growth or regression: powered by inflammation. J Leukoc Biol 2006 80 : 685 90.
30. Kim R, Emi M, Tanabe K. Cancer immunoediting from immune surveillance to immune escape. Immunology 2007 121 : 1 14.
31. Esposito I, Menicagli M, Funel N et al. Inflammatory cells contribute to the generation of an angiogenic phenotype in pancreatic ductal adenocarcinoma. J Clin Pathol 2004 57 : 630 6.
32. Garcea G, Dennison AR, Steward WP, Berry DP. Role of inflammation in pancreatic carcinogenesis and the implications for future therapy. Pancreatology 2005 5 : 514 29.
33. Charo IF, Ransohoff RM. The many roles of chemokines and chemokine receptors in inflammation. N Engl J Med 2006 354 : 610 21.
34. Murdoch C, Finn A. Chemokine receptors and their role in inflammation and infectious diseases. Blood 2000 95 : 3032 43.
35. Murphy PM. Chemokines and the molecular basis of cancer metastasis. N Engl J Med 2001 345 : 833 5.
36. Romagnani P, Lasagni L, Annunziato F, Serio M, Romagnani S. CXC chemokines: the regulatory link between inflammation and angiogenesis. Trends Immunol 2004 25 : 201 9.
37. Strieter RM, Burdick MD, Gomperts BN, Belperio JA, Keane MP. CXC chemokines in angiogenesis. Cytokine Growth Factor Rev 2005 16 : 593 609.
38. Koizumi K, Hojo S, Akashi T, Yasumoto K, Saiki I. Chemokine receptors in cancer metastasis and cancer cell-derived chemokines in host immune response. Cancer Sci 2007 98 : 1652 8.
39. Lenoir M, Djerdjouri B, Perianin A. Stroma cell-derived factor 1alpha mediates desensitization of human neutrophil respiratory burst in synovial fluid from rheumatoid arthritic patients. J Immunol 2004 172 : 7136 43.
40. Lu Y, Wang J, Xu Y et al. CXCL16 functions as a novel chemotactic factor for prostate cancer cells in vitro. Mol Cancer Res 2008 6 : 546 54.
41. Agostini C, Cabrelle A, Calabrese F et al. Role for CXCR6 and its ligand CXCL16 in the pathogenesis of T-cell alveolitis in sarcoidosis. Am J Respir Crit Care Med 2005 172 : 1290 8.
42. Garcia GE, Truong LD, Li P et al. Inhibition of CXCL16 attenuates inflammatory and progressive phases of anti- glomerular basement membrane antibody-associated glomerulonephritis. Am J Pathol 2007 170 : 1485 96.
43. Koprak S, Matheravidathu S, Springer M, Gould S, Dumont FJ. Down-regulation of cell surface CXCR6 expression during T cell activation is predominantly mediated by calcineurin. Cell Immunol 2003 223 : 1 12.
44. Arraes SM, Freitas MS, da Silva SV et al. Impaired neutrophil chemotaxis in sepsis associates with GRK expression and inhibition of actin assembly and tyrosine phosphorylation. Blood 2006 108 : 2906 13.